
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Stiripentol is a drug that reduces seizures by modulating GABA receptors, especially for patients with Dravet syndrome. It has demonstrated significant efficacy in clinical trials,···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:533
Stiripentol was approved by the FDA in 2018 for significantly improving seizure frequency and improving the quality of life of infants and young children suffering from Dravet synd···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:582
Patients with Dravet syndrome often find it difficult to control seizures with traditional drugs, and Stiripentol, as a new type of drug, has shown significant clinical effects by ···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:496
Stiripentol provides new hope for patients with epilepsy that cannot be effectively controlled by enhancing the action of GABA receptors for the treatment of seizures in Dravet syn···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:510
Stiripentol is specifically used in the treatment of Dravet syndrome-related seizures by modulating GABA receptors and reducing the frequency of generalized clonic seizures. Clinic···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:521
Dravet syndrome is a rare and refractory epileptic encephalopathy, and Stiripentol is widely used to improve the seizure status of patients by inhibiting the hepatocytochrome P450 ···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:502
Stiripentol is an innovative antiepileptic drug used to treat Dravet syndrome, mainly by enhancing GABAergic nerve conduction and reducing the frequency of seizures in patients. In···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:423
Fidaxomicin is a white to off-white film-coated oblong tablet and should be used as directed by a healthcare practitioner.How much do the different versions of Fidaxomicin cost?Pri···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:533
Fidaxomicin works by inhibiting the RNA polymerase of bacteria, which has little damage to normal intestinal colonies and is highly safe.How many versions of Fidaxomicin are there?···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:544
Fidaxomicin is a macrolide antibiotic developed by Optimer and approved by the FDA in 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD).What is Fidaxomicin···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:614
Balversa is specifically designed for patients with advanced urothelial carcinoma, targeting patients with FGFR mutations and bringing new hope to patients by inhibiting cancer cel···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:486
Balversa is a targeted drug targeting FGFR mutations for the treatment of advanced urothelial carcinoma, inhibiting cancer cell growth by inhibiting the FGFR signaling pathway, pro···【more】
Article source:Captain MedicineRelease date:2024-08-28Recommended:604
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:8532025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:10502024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended:3122026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:4052026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:5982026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:5742026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:4572026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:6082026-31-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643